For Most Children With Alopecia Areata, No Systemic Drug Is Approved Yet

A new retrospective study on predictors of systemic treatment response in pediatric alopecia areata went online this month with no public abstract yet, but the treatment landscape it examines is checkable now: only one systemic drug is FDA-approved for children with the condition, and only for ages twelve and up.